Genetic variation in the ASIC3 gene influences blood pressure levels in Taiwanese

Journal of Hypertension

Volumn 26, Issue 11, 2008, Pages 2154-2160

  Ko, Yu Lin ^a   Hsu, Lung An ^b   Wu, Semon ^c   Teng, Ming Sheng ^c   Chang, Hsien Hsun ^c   Chen, Chih Cheng ^d   Cheng, Ching Feng ^a,d  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c Department of Medical Education and Research ^*  (Taiwan)

^d INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Acid sensing ion channel 3 gene; Blood pressure; Exonic splicing enhancer; Genetic association studies; Hypertension; Polymorphism; Population science

Indexed keywords

GENOMIC DNA; ACCN3 PROTEIN, HUMAN; SODIUM CHANNEL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASIAN; ASIC3 GENE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HUMAN; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; MEDICAL EXAMINATION; MISSENSE MUTATION; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SPLICING DEFECT; SYSTOLIC BLOOD PRESSURE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; BLOOD PRESSURE; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; TAIWAN;

ADULT; AGED; BLOOD PRESSURE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SODIUM CHANNELS; TAIWAN;

EID: 56049104472     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32830e251b     Document Type: Article

References (35)

1. Yeh CJ, Pan WH, Jong YS, Kuo YY, Lo CH. Incidence and predictors of isolated systolic hypertension and isolated diastolic hypertension in Taiwan. J Formos Med Assoc 2001; 100:668-675.
2. Wolf-Maier K, Cooper RS, Banegas JR,Giampaoli S, Hense HW, JoffresM, et al. Hypertension, prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289:2363- 2369.
3. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. INTERHEART study investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (theINTERHEART study): case-control study. Lancet 2004; 364:937-952.
4. Harrap SB. An appraisal of the genetic approaches to high blood pressure. J Hypertens 1996; 14:S111-S115.
5. Mein CA, Caulfield MJ, Dobson RJ, Munroe PB. Genetics of essential hypertension. Hum Mol Genet 2004; 13:169-175.
6. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104:545-556.
7. Binder A. A review of the genetics of essential hypertension. Curr Opin Cardiol 2007; 22:176-184.
8. Waldmann R, Champigny G, Bassilana F, Heurteaux C, Lazdunski M. A proton-gated cation channel involved in acid-sensing. Nature 1997;386:173-177.
9. + absorption. Am J Physiol 1997; 273:G571-G585.
10. Kellenberger S, Schild L. Epithelial sodium channel/degenerin family of ion channels: a variety of functions for a shared structure. Physiol Rev 2002;82:735-767.
11. Waldmann R, Lazdunski M. H(+)-gated cation channels: neuronal acid sensors in the NaC/DEG family of ion channels. Curr Opin Neurobiol 1998; 8:418-424.
12. + channel on ischemia-sensing neurons. Nat Neurosci 2001; 4:869-870.
13. + channel. J Biol Chem 1995; 270:27411-27414.
14. Babinski K, Le KT, Seguela P. Molecular cloning and regional distribution of a human proton receptor subunit with biphasic functional properties. J Neurochem 1999; 72:51-57.
15. Yagi J, Wenk HN, Naves LA, McCleskey EW. Sustained currents through ASIC3 ion channels at the modest pH changes that occur during myocardial ischemia. Circ Res 2006; 99:501-509.
16. Gao Z, Henig O, Kehoe V, Sinoway LI, Li J. Vanilloid type 1 receptor and the acid-sensing ion channel mediate acid phosphate activation of muscle afferent nerves in rats. J Appl Physiol 2006; 100:421-426.
17. Tan ZY, Lu Y, Whiteis CA, Benson CJ, Chapleau MW, Abboud FM. Acid- sensing ion channels contribute to transduction of extracellular acidosis in rat carotid body glomus cells. Circ Res 2007; 101:1009-1019.
18. Cheng CF, Yang KC, Kuo TBJ, Chen CC. Loss of ASIC3 results in abnormal cardiac autonomic regulation and increased cardiac ischemia susceptibility in mice. Int J Cardiol 2007; 122 (Suppl. 1):47 (abstract).
19. Lin TH, Chiu HC, Su HM, Juo SH, Lee YT, VoonWC, et al. D-allele of ACE polymorphism is associated with increased magnitude of QT dispersion prolongation in elderly Chinese: 4-year follow-up study. Circ J 2007;71:39-45.
20. Hsu LA, Ko YL, Hsu KH, Ko YH, Lee YS. Genetic variations in the cholesteryl ester transfer protein gene and high density lipoprotein cholesterol levels in Taiwanese Chinese. Hum Genet 2002; 110:57-63.
21. Tregouet DA,Garelle V. A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics 2007;23:1038-1039.
22. Fairbrother WG, Yeh RF, Sharp PA, Burge CB. Predictive Identification of exonic splicing enhancers in human genes. Science 2002; 297:1007-1013.
23. Fairbrother WG, Holste D, Burge CB, Sharp PA. Single nucleotide polymorphism-based validation of exonic splicing enhancers. PLoS Biol 2004; 2:E268.
24. Cooper TA, MattoxW. The regulation of splice-site selection, and its role in human disease. Am J Hum Genet 1997; 61:259-266.
25. Graveley BR. Alternative splicing: increasing diversity in the proteomicworld. Trends Genet 2001; 17:100-107.
26. Carlini DB, Genut JE. Synonymous SNPs provide evidence for selective constraint on human exonic splicing enhancers. J Mol Evol 2006; 62:89-98.
27. Aretz S, Uhlhaas S, Sun Y, Pagenstecher C, Mangold E, Caspari R, et al. Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene. Hum Mutat 2004; 24:370-380.
28. Disset A, Bourgeois CF, Benmalek N, Claustres M, Stevenin J, Tuffery- Giraud S. An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements. Hum Mol Genet 2006; 15:999-1013.
29. Petkovic V, Lochmatter D, Turton J,Clayton PE, Trainer PJ, DattaniMT, et al. Exon splice enhancer mutation (GH-E32A) causes autosomal dominant GH deficiency. J Clin Endocrinol Metab 2007; 92:4427-4435.
30. Zhu H, Tucker HM, Grear KE, Simpson JF, Manning AK, upples LA, Estus S. A common polymorphism decreases low-density lipoprotein receptor exon 12 splicing efficiency and associates with increased cholestero. Hum Mol Genet 2007; 16:1765-1772.
31. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, et al. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994; 79:407-414.
32. Hansson JH, Nelson-Williams C, Suzuki H, Schild L, Shimkets R, Lu Y, et al. Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nat Genet 1995; 11:76-82.
33. (+) channel 3 and cystic fibrosis transmembrane conductance regulator. J Biol Chem 2006; 281:36960-36968.
34. Smith SA, Mitchell JH, Garry MG. The mammalian exercise pressor refiex in health and disease. Exp Physiol 2006; 91:89-102.
35. Kristal O. The ASICs: signaling molecules Modulators Trends Neurosci 2003; 26:477-483.